For clinical research sales teams

Know which oncology trials need you before the RFP goes out.

Pharma Pulse sends your team new US oncology studies, new investigator sites and enrollment changes every week, each tagged with why it matters to what you sell.

  • 2,997 open US industry oncology studies watched
  • 1 Phase 3 for 520 patients with 1 site listed
  • 37 US sites waiting to start enrolling on a single study

Sample leads

What lands in your inbox

Three real leads from this week's feed. Sponsor names are held back here; subscribers get the sponsor, study and every listed site.

New trial

Phase 3 | Metastatic urothelial cancer | HER2-expressing

Target 520 patients. 1 US site live. Registered Oct 13.

Why it matters: site expansion and HER2 testing ahead.

Good for: site networks, recruitment, specialty labs.

Sites about to activate

Phase 3 | Metastatic hormone-sensitive prostate cancer

Target 1,330 patients. 42 US sites in 20 states: 3 enrolling, 37 not yet enrolling, 2 dropped out.

Why it matters: 37 US sites switch on in the coming months, and 2 need replacing.

Good for: recruitment, site networks, start-up and feasibility.

Radioligand, 8 academic sites

Phase 2a | Relapsed clear cell renal cell carcinoma | Lutetium-177

Target 40 patients. 8 US academic sites named, none enrolling yet. Planned start date has passed.

Why it matters: every site needs radiopharmacy delivery and dosimetry coordination, all at once.

Good for: specialty logistics, site networks.

Who it's for

Built for the vendors oncology studies depend on

Patient recruitment

Studies where enrollment pain is coming.

Site networks

New studies that still need US sites, in your states.

Specialty labs

Biomarker-selected studies the week they appear.

eClinical sales

Emerging biotechs launching their first studies.

Specialty logistics

Radioligand, cell therapy and ADC studies opening new sites.

How it works

Three steps to a better call list

  1. 1

    Tell us what you sell and where.

    Category, tumor types, phases, states.

  2. 2

    We watch the oncology trial landscape every day.

    New studies, new sites, status and timeline changes, filtered to your fit.

  3. 3

    You get a short list with the reason to call.

    Email plus CSV, ready for your CRM. Each lead says what changed and why it fits you.

Signals we track

  • New industry-sponsored studies
  • New US sites
  • Sites moving to enrolling
  • Sites dropping out
  • Phase changes
  • Enrollment status changes
  • Completion dates moving

Coverage

Today: US, industry-sponsored, interventional oncology. More therapeutic areas when our customers ask for them.

Pricing

Two plans. Cancel any time.

Starter

$199/mo

Delivery
Weekly email + CSV
Events
New studies, status changes
Filters
Tumor type or phase
Seats
1
Start Starter

Prefer to talk first? Book a 30-min call or email hello@pharma-pulse.io.

Not sure? Get 5 free leads in your category first. 30 day money back on your first month. Founding pricing locked for our first 10 customers.

FAQ

Questions vendors ask

What exactly is a lead?

One study event: a new study, a new site, or a change in enrollment status or timeline, with sponsor, phase, size, sites and a one line reason it fits what you sell.

Do you include contact names?

We give you the sponsor and the sites. Your team uses its own contact tools to reach the right person. That keeps the list accurate and compliant.

How fresh is it?

Core checks every day. Starter is a weekly roundup.

Which areas do you cover?

US industry-sponsored oncology studies. If you need another area, tell us and we will scope it.

How is this different from big trial databases?

Those are research tools priced for sponsors. Pharma Pulse is a sales feed: only what changed, only what fits you, with the reason to call.

Can I try it first?

Yes. Ask for 5 free leads in your category.

Can I cancel?

Any time, from your billing link. First month is money back if it is not useful.

Where does the information come from?

Public study disclosures and sponsor announcements, checked daily and organized by our own change tracking.

See your next five leads this week.

Tell us what you sell, which tumor types and which states. We will send 5 leads that fit, free.

Get 5 free leads in your category